Innate Pharma S.A.
Innate Pharma S.A. (IPHYF) Stock Technical Analysis & Trading Signals
Live technical indicators, trading signals, and momentum insights for Innate Pharma S.A. (PNK:IPHYF).
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full DisclaimerIPHYF Technical Analysis Summary
Innate Pharma S.A. stock currently trades in a neutral range, with no clear dominance from buyers or sellers.
Overall, Innate Pharma S.A. remains neutral, with indicators showing mixed momentum.
RSI (14): 54.24
Stochastic %K: 100.00
Williams %R: 0.00
Rate of Change (ROC): 0.00
Takeaway:Insufficient data to determine overall momentum trend.
MACD: 0.01
ADX: 18.58
ATR (14): 0.02
CCI (14): 35.90
Takeaway:Innate Pharma S.A. shows a neutral trend, with weak conviction and limited volatility.
Takeaway:Innate Pharma S.A. trades near the lower band, signaling oversold conditions and potential rebound.
Takeaway:Innate Pharma S.A. trades near the lower channel, signaling strong support and possible rebound.
Overall Takeaway:IPHYF shows mixed signals in money flow analysis.
Bullish Signals
RSI above 50 → positive momentum from buyers.
MACD above 0 → bullish trend confirmation.
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
MACD below signal line → short-term caution on momentum.
RVI below 50 → vigor tilted toward sellers.
Overall Recommendation:Innate Pharma S.A. shows a Neutral outlook — indicators suggest balanced momentum with no clear directional trend.